TCS launches AI platform to speed up drug development

Tata Consultancy Services (TCS) has launched TCS ADD AgentHub, a platform that uses agentic artificial intelligence to automate repetitive tasks in pharmaceutical drug development and clinical trials. The platform is designed for the highly regulated pharma industry and keeps humans in charge of critical decisions and governance.

TCS says the platform can deploy specialised AI agents for tasks such as data entry, case report intake, literature analysis, protocol digitisation and study design. The company reported efficiency gains of up to 40% in clinical data management and up to 30% reduction in clinical study build effort. It also claimed up to 30% cost savings in safety case processing and up to 50% reduction in quality control effort.

Debashish Ghosh, president of Lifesciences and Healthcare at TCS, said the platform enables a shift from reactive to proactive, scalable and audit-ready operations. Companies can build their own agent hub and integrate the platform with existing systems.